Abstract
Several molecular mechanisms are involved in the regulation of skeletal muscle function. Among them, mitochondrial activity can be identified. The mitochondria is an important and essential organelle in the skeletal muscle that is involved in metabolic regulation and ATP production, which are two key elements of muscle contractibility and plasticity. Thus, in this review, we present the critical and recent antecedents regarding the mechanisms through which mitochondrial dysfunction can be involved in the generation and development of skeletal muscle pathologies, its contribution to detrimental functioning in skeletal muscle and its crosstalk with other typical signaling pathways related to muscle diseases. In addition, an update on the development of new strategies with therapeutic potential to inhibit the deleterious impact of mitochondrial dysfunction in skeletal muscle is discussed.
Original language | English |
---|---|
Pages (from-to) | 536-546 |
Number of pages | 11 |
Journal | Current Protein and Peptide Science |
Volume | 20 |
Issue number | 6 |
DOIs | |
State | Published - 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 Bentham Science Publishers.
Keywords
- ATP production
- Atrophy
- Dystrophy
- Mitochondria
- ROS
- Skeletal muscle